BCL11B Is Up-Regulated by EWS/FLI and Contributes to the Transformed Phenotype in Ewing Sarcoma

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Wiles, Elizabeth T ^a   Lui Sargent, Bianca ^b   Bell, Russell ^b   Lessnick, Stephen L ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL CHRONIC LYMPHOCYTIC LEUKEMIA LYMPHOMA 11B; BINDING PROTEIN; DNA; FLI PROTEIN; HISTONE DEACETYLASE; NUCLEOSOME REMODELING AND HISTONE DEACETYLASE; RNA BINDING PROTEIN EWS; SPROUTY 1 PROTEIN; SPROUTY PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ARTICLE; B CELL CHRONIC LYMPHOCYTIC LEUKEMIA LYMPHOMA 11B GENE; BINDING AFFINITY; BINDING SITE; CANCER CELL CULTURE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; EWING SARCOMA; GENE IDENTIFICATION; MOLECULAR PATHOLOGY; ONCOGENE; PHENOTYPE; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPRESSOR GENE; SIGNAL TRANSDUCTION; UPREGULATION;

BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MEMBRANE PROTEINS; MI-2 NUCLEOSOME REMODELING AND DEACETYLASE COMPLEX; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PHOSPHOPROTEINS; PROTO-ONCOGENE PROTEIN C-FLI-1; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEIN EWS; SARCOMA, EWING; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, RNA; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEINS;

EID: 84875106495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059369     Document Type: Article

References (55)

1. Arndt CA, Crist WM, (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342-352.
2. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, et al. (1992) Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 359: 162-165.
3. Turc-Carel C, Aurias A, Mugneret F, Lizard S, Sidaner I, et al. (1988) Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). Cancer Genet Cytogenet 32: 229-238.
4. Shukla N, Ameur N, Yilmaz I, Nafa K, Lau CY, et al. (2012) Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways. Clin Cancer Res 18: 748-757.
5. Huang HY, Illei PB, Zhao Z, Mazumdar M, Huvos AG, et al. (2005) Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse. J Clin Oncol 23: 548-558.
6. Kinsey M, Smith R, Lessnick SL, (2006) NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. Mol Cancer Res 4: 851-859.
7. Smith R, Owen LA, Trem DJ, Wong JS, Whangbo JS, et al. (2006) Expression profiling of EWS/FLI identifies NKX2.2 as a critical target gene in Ewing's sarcoma. Cancer Cell 9: 405-416.
8. Prieur A, Tirode F, Cohen P, Delattre O, (2004) EWS/FLI-1 silencing and gene profiling of Ewing cells reveal downstream oncogenic pathways and a crucial role for repression of insulin-like growth factor binding protein 3. Mol Cell Biol 24: 7275-7283.
9. Owen LA, Kowalewski AA, Lessnick SL, (2008) EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma. PLoS One 3: e1965.
10. Zwerner JP, Joo J, Warner KL, Christensen L, Hu-Lieskovan S, et al. (2008) The EWS/FLI1 oncogenic transcription factor deregulates GLI1. Oncogene 27: 3282-3291.
11. Hahm KB, Cho K, Lee C, Im YH, Chang J, et al. (1999) Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein. Nat Genet 23: 222-227.
12. Avram D, Fields A, Pretty On Top K, Nevrivy DJ, Ishmael JE, et al. (2000) Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem 275: 10315-10322.
13. Staege MS, Hutter C, Neumann I, Foja S, Hattenhorst UE, et al. (2004) DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets. Cancer Res 64: 8213-8221.
14. Kauer M, Ban J, Kofler R, Walker B, Davis S, et al. (2009) A molecular function map of Ewing's sarcoma. PLoS One 4: e5415.
15. Riggi N, Suva ML, De Vito C, Provero P, Stehle JC, et al. (2010) EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes Dev 24: 916-932.
16. von Levetzow C, Jiang X, Gwye Y, von Levetzow G, Hung L, et al. (2011) Modeling initiation of Ewing sarcoma in human neural crest cells. PLoS One 6: e19305.
17. Deneen B, Welford SM, Ho T, Hernandez F, Kurland I, et al. (2003) PIM3 proto-oncogene kinase is a common transcriptional target of divergent EWS/ETS oncoproteins. Mol Cell Biol 23: 3897-3908.
18. Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, et al. (2003) Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol 4: 533-539.
19. Golonzhka O, Liang X, Messaddeq N, Bornert JM, Campbell AL, et al. (2009) Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation. J Invest Dermatol 129: 1459-1470.
20. Golonzhka O, Metzger D, Bornert JM, Bay BK, Gross MK, et al. (2009) Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis. Proc Natl Acad Sci U S A 106: 4278-4283.
21. Chen B, Wang SS, Hattox AM, Rayburn H, Nelson SB, et al. (2008) The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Natl Acad Sci U S A 105: 11382-11387.
22. Arlotta P, Molyneaux BJ, Chen J, Inoue J, Kominami R, et al. (2005) Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 45: 207-221.
23. Li L, Leid M, Rothenberg EV, (2010) An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329: 89-93.
24. Simon R, Brylka H, Schwegler H, Venkataramanappa S, Andratschke J, et al. (2012) A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis. EMBO J 31: 2922-2936.
25. Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, et al. (2011) The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 118: 4169-4173.
26. De Keersmaecker K, Real PJ, Gatta GD, Palomero T, Sulis ML, et al. (2010) The TLX1 oncogene drives aneuploidy in T cell transformation. Nat Med 16: 1321-1327.
27. Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, et al. (2003) Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 301: 598-603.
28. Braunreiter CL, Hancock JD, Coffin CM, Boucher KM, Lessnick SL, (2006) Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma. Cell Cycle 5: 2753-2759.
29. Gangwal K, Close D, Enriquez CA, Hill CP, Lessnick SL, (2010) Emergent Properties of EWS/FLI Regulation via GGAA Microsatellites in Ewing's Sarcoma. Genes Cancer 1: 177-187.
30. Bailly RA, Bosselut R, Zucman J, Cormier F, Delattre O, et al. (1994) DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Mol Cell Biol 14: 3230-3241.
31. Sankar S, Bell R, Stephens B, Zhou R, Sharma S, et al. (2012) Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene in press.
32. Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, et al. (2003) Telomerase maintains telomere structure in normal human cells. Cell 114: 241-253.
33. Grabarczyk P, Nahse V, Delin M, Przybylski G, Depke M, et al. (2010) Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation. PLoS One 5.
34. Lessnick SL, Dacwag CS, Golub TR, (2002) The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell 1: 393-401.
35. Hu-Lieskovan S, Zhang J, Wu L, Shimada H, Schofield DE, et al. (2005) EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors. Cancer Res 65: 4633-4644.
36. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
37. Schaefer KL, Eisenacher M, Braun Y, Brachwitz K, Wai DH, et al. (2008) Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer 44: 699-709.
38. May WA, Lessnick SL, Braun BS, Klemsz M, Lewis BC, et al. (1993) The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1. Mol Cell Biol 13: 7393-7398.
39. Avram D, Fields A, Senawong T, Topark-Ngarm A, Leid M, (2002) COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. Biochem J 368: 555-563.
40. Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, et al. (2005) BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene 24: 6753-6764.
41. Topark-Ngarm A, Golonzhka O, Peterson VJ, Barrett B Jr, Martinez B, et al. (2006) CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene. J Biol Chem 281: 32272-32283.
42. Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, et al. (2007) Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26: 412-423.
43. Cherrier T, Suzanne S, Redel L, Calao M, Marban C, et al. (2009) p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28: 3380-3389.
44. Senawong T, Peterson VJ, Avram D, Shepherd DM, Frye RA, et al. (2003) Involvement of the histone deacetylase SIRT1 in chicken ovalbumin upstream promoter transcription factor (COUP-TF)-interacting protein 2-mediated transcriptional repression. J Biol Chem 278: 43041-43050.
45. Wang Y, Zhang H, Chen Y, Sun Y, Yang F, et al. (2009) LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 138: 660-672.
46. Gross I, Bassit B, Benezra M, Licht JD, (2001) Mammalian sprouty proteins inhibit cell growth and differentiation by preventing ras activation. J Biol Chem 276: 46460-46468.
47. Silvany RE, Eliazer S, Wolff NC, Ilaria RL Jr, (2000) Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation. Oncogene 19: 4523-4530.
48. Gangwal K, Sankar S, Hollenhorst PC, Kinsey M, Haroldsen SC, et al. (2008) Microsatellites as EWS/FLI response elements in Ewing's sarcoma. Proc Natl Acad Sci U S A 105: 10149-10154.
49. Kominami R, (2012) Role of the transcription factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser B Phys Biol Sci 88: 72-87.
50. Nagel S, Kaufmann M, Drexler HG, MacLeod RA, (2003) The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). Cancer Res 63: 5329-5334.
51. Le Douce V, Colin L, Redel L, Cherrier T, Herbein G, et al. (2012) LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing. Nucleic Acids Res 40: 1904-1915.
52. Tang B, Di Lena P, Schaffer L, Head SR, Baldi P, et al. (2011) Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling. PLoS One 6: e23691.
53. Bailey TL, Boden M, Buske FA, Frith M, Grant CE, et al. (2009) MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 37: W202-208.
54. Beauchamp E, Bulut G, Abaan O, Chen K, Merchant A, et al. (2009) GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J Biol Chem 284: 9074-9082.
55. Navarro D, Agra N, Pestana A, Alonso J, Gonzalez-Sancho JM, (2010) The EWS/FLI1 oncogenic protein inhibits expression of the Wnt inhibitor DICKKOPF-1 gene and antagonizes beta-catenin/TCF-mediated transcription. Carcinogenesis 31: 394-401.